VOLKAN BAYAR
Trends in Pediatrics - 2022;3(2):54-57
Lercanidipine is a 1,4-dihydropyridine calcium channel blocker. For severe toxicity, treatment modalities are based on a restricted range of evidence and clinical experience. This case report describes our clinical experience regarding the treatment of Lercanidipine overdose in a 16-year-old girl. To the best of our knowledge, this is the first reported pediatric case overdose of lercanidipine.
